Orphanet: Simple search
x

Search for a diagnostic test

* (*) mandatory field

42 Result(s)

Filter by

Speciality(ies)/objective(s)

Technique(s)

Purpose(s)

Quality management

Country(ies)

Reset
Sort by

Caption : Accreditation =Accreditation ;

GERMANY

Nordrhein-Westfalen
DORTMUND

Accreditation Analysis of susceptibility for narcolepsy (HLA-DQB1, HLA-DRB1)
Medizinisches Versorgungszentrum (MVZ) Dr. Eberhard und Partner
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : PCR based techniques

More information
GERMANY

Nordrhein-Westfalen
BAD OEYNHAUSEN

Accreditation Analysis of susceptibility for narcolepsy (HLA-DQ, HLA-DR)
Ruhr-Universität Bochum
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

More information
GERMANY

Bayern
MÜNCHEN

Accreditation HLA-genotyping: susceptibility for narcolepsy - testing of DR15 DQB1*0602
Medizinisch Genetisches Zentrum München
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

More information
UNITED KINGDOM

Greater London
LONDON

Accreditation Analysis of susceptibility for narcolepsy (HLA-DQB1*15, HLA-DRB1*06)
The Doctors Laboratory Ltd
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

More information
FRANCE

HAUTS-DE-FRANCE
LILLE

Accreditation Diagnosis of susceptibility to narcolepsy-cataplexy (HLA-DQB1 genotyping)
CHU de Lille - Centre de Biologie Pathologie Génétique
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : PCR based techniques

More information
FRANCE

ILE-DE-FRANCE
PARIS

Accreditation Diagnosis of susceptibility to narcolepsy with cataplexy (HLA-DQB1 gene)
AP-HP.Sorbonne Université - Hôpital de la Pitié-Salpêtrière
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
FRANCE

AUVERGNE-RHONE-ALPES
DÉCINES CHARPIEU

Accreditation Diagnosis of susceptibility to narcolepsy-cataplexy (HLA-DQB1, HLA-DRB1 genes)
Établissement Français du Sang - Auvergne Rhône-Alpes
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
FRANCE

ILE-DE-FRANCE
PARIS

Accreditation Diagnosis of susceptibility to narcolepsy-cataplexy (HLA-DQB1 gene)
CHU Paris - Hôpital Robert Debré
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : PCR based techniques

More information
FRANCE

AUVERGNE-RHONE-ALPES
LA TRONCHE

Accreditation Diagnosis of susceptibility to narcolepsy-cataplexy (HLA-DQB1, HLA-DRB1 genes: PCR-SSO)
Établissement Français du Sang - Rhône Alpes - Grenoble
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
FRANCE

BRETAGNE
RENNES

Accreditation Diagnosis of susceptibility to narcolepsy with or without cataplexy (HLA-DQB1)
Établissement Français du Sang - Bretagne
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES), PCR based techniques

More information
GERMANY

Baden-Württemberg
TÜBINGEN

Accreditation Diagnosis of narcolepsy (HCRT gene)
CeGaT GmbH
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
FRANCE

ILE-DE-FRANCE
SAINT-OUEN-L'AUMÔNE

Accreditation Diagnosis of susceptibility to narcolepsy with or without cataplexy (HLA-DQB1 genotyping)
Laboratoire Cerba
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : PCR based techniques

More information
GERMANY

Bayern
MÜNCHEN

Accreditation Diagnosis of narcolepsy (HCRT gene)
Pränatal-Medizin München MVZ GmbH
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
FRANCE

GRAND-EST
STRASBOURG

Accreditation Diagnosis of susceptibility to rheumatoid arthritis (HLA-DRB1 and HLA-DQB1 genes)
Établissement Français du Sang - Grand Est
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
FRANCE

PAYS DE LA LOIRE
ANGERS

Accreditation Diagnosis of susceptibility to narcolepsy with or without cataplexy (HLA-DQB1 gene)
Établissement Français du Sang - Angers
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : PCR based techniques

More information
FRANCE

BOURGOGNE-FRANCHE-COMTE
BESANÇON

Accreditation Diagnosis of susceptibility to narcolepsy with cataplexy (HLA-DQB1*06:02 gene)
Établissement Français du Sang - Bourgogne/Franche-Comté
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
GERMANY

Bayern
MÜNCHEN

Accreditation Analysis of susceptibility for narcolepsy (HLA-DQB1, HLA-DRB1)
Zweigniederlassung der SYNLAB MVZ Augsburg GmbH
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
FRANCE

NOUVELLE AQUITAINE
POITIERS

Accreditation Diagnosis of susceptibility to narcolepsy-cataplexy syndrome (HLA-DQB1 gene)
Établissement Français du Sang - Poitiers
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : NGS sequencing (except WES), PCR based techniques

More information
FRANCE

BRETAGNE
BREST

Accreditation Diagnosis of susceptibility to narcolepsy-cataplexy (HLA-DQB1 gene)
CHU de Brest - Hôpital de la Cavale Blanche
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
FRANCE

CENTRE-VAL DE LOIRE
TOURS

Accreditation Diagnosis of predisposition to narcolepsy type 1 (HLA-DQB1*06:02 gene)
Établissement Français du Sang - Centre Pays de la Loire
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
FRANCE

AUVERGNE-RHONE-ALPES
CLERMONT-FERRAND

Accreditation Diagnosis of susceptibility to narcolepsy syndrome (HLA-DQB1 gene)
CHU de Clermont-Ferrand - Hôpital Gabriel Montpied
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : PCR based techniques

More information
FRANCE

AUVERGNE-RHONE-ALPES
CLERMONT-FERRAND

Accreditation Genotyping of HLA-DRB1 and HLA-DQB1 genes by PCR SSP or PCR SSO
Laboratoire de biologie médicale GEN-BIO
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
BELGIUM

VLAAMS BRABANT
LEUVEN

Accreditation Diagnosis of narcolepsy with or without cataplexy (HLA-DQB1 gene)
UZ Leuven - Campus Gasthuisberg
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
FRANCE

BOURGOGNE-FRANCHE-COMTE
BESANÇON

Accreditation Diagnosis of HLA related diseases (HLA typing)
Etablissement Français de Sang
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : NGS sequencing (except WES), PCR based techniques

More information
FRANCE

NORMANDIE
BOIS GUILLAUME

Accreditation Diagnosis of HLA related diseases (HLA typing)
EFS HFNO
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : NGS sequencing (except WES), PCR based techniques

More information
FRANCE

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE

Accreditation Diagnosis of susceptibility to narcolepsy with or without cataplexy (HLA-DQB1 gene)
Établissement Français du Sang - PACA-Corse
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : NGS sequencing (except WES)

More information
SWITZERLAND

Suisse Romande
GENÈVE

Accreditation Molecular diagnosis of susceptibilty to narcolepsy with or without cataplexy (HLA-DQB1 gene)
Hôpitaux Universitaires de Genève HUG
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
GERMANY

Nordrhein-Westfalen
KÖLN

Analysis of susceptibility for narcolepsy (HLA-DQB1, HLA-DRB1)
Zotz|Klimas Standort Köln
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

More information
GERMANY

Sachsen
DRESDEN

Analysis of susceptibility for narcolepsy (HLA-DQB1, HCRT, MOG genes)
Gemeinschaftspraxis für Humangenetik
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

More information
ITALY

LAZIO
ROMA

Molecular diagnosis of suceptibility to narcolepsy (HLA-DQA1, HLA-DQB1 genes)
Azienda Ospedaliera S. Camillo-Forlanini - Ospedale San Camillo
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics

More information
ITALY

TOSCANA
PRATO

Molecular diagnosis of susceptibility to narcolepsy (HAL-DQB1 gene)
USL4 - Nuovo Ospedale Santo Stefano
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

More information
FRANCE

PROVENCE-ALPES-COTE D'AZUR
NICE

Diagnosis of susceptibility to narcolepsy with cataplexy (HLA-DQB1 and HLA-DRB1 genotyping)
CHU de Nice - Hôpital l'Archet 1
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : PCR based techniques

More information
FRANCE

NOUVELLE AQUITAINE
BORDEAUX

Diagnosis of susceptibility to narcolepsy with or without cataplexy (HLA-DQB1 genotyping)
CHU de Bordeaux-GH Pellegrin
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
FRANCE

ILE-DE-FRANCE
PARIS

Diagnosis of susceptibility to narcolepsy with or without cataplexy (HLA-DQB1 gene ; PCR-SSO)
GHU AP-HP Nord. Université de Paris - Hôpital Saint-Louis
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
FRANCE

GRAND-EST
REIMS

Diagnosis of predisposition to narcolepsy-cataplexy (HLA-DQB1*06:02 gene)
CHU de Reims - Hôpital Robert Debré
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
SPAIN

Cataluña
ESPLUGUES DE LLOBREGAT

Diagnosis of neurotransmitter defects and related diseases (panel)
Hospital Sant Joan de Déu Barcelona
Purpose(s) : Antenatal diagnosis, Post-natal diagnosis, Pre-symptomatic diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Cataluña
ESPLUGUES DE LLOBREGAT

Diagnosis of Rett syndrome and epilepsy (panel)
Hospital Sant Joan de Déu Barcelona
Purpose(s) : Antenatal diagnosis, Post-natal diagnosis, Pre-symptomatic diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Cataluña
ESPLUGUES DE LLOBREGAT

Diagnosis of vasculopathy (panel)
Hospital Sant Joan de Déu Barcelona
Purpose(s) : Antenatal diagnosis, Post-natal diagnosis, Pre-symptomatic diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

More information
ITALY

EMILIA ROMAGNA
FERRARA

Diagnosis of narcolepsy types 1 and 2 (HLA-DQB1, HLA-DRB1 genes)
A.O.U. Sant'Anna - Polo Chimico-Bio-Medico
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : PCR based techniques

More information
SPAIN

País Vasco
SAN SEBASTIÁN

Diagnosis of narcolepsy (panel)
DNA Data
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

More information
FRANCE

OCCITANIE
TOULOUSE

Diagnosis of predisposition to narcolepsy type 1 (HLA-DQB1*06:02 gene)
CHU de Toulouse - Hôpital Purpan
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : PCR based techniques

More information
PORTUGAL

CENTRO
OEIRAS

Analysis of susceptibility for Narcolepsy-cataplexy and Narcolepsy without cataplexy (HLA-DQB1 and HLA-DRB1 gene)
Laboratório de Análises Clínicas Dr. Joaquim Chaves
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

More information